<aside> <img src="notion://custom_emoji/3b7b79b0-95af-4500-931c-e5c63e5df242/23ac6f79-9a33-80da-9908-007ae96e1d8b" alt="notion://custom_emoji/3b7b79b0-95af-4500-931c-e5c63e5df242/23ac6f79-9a33-80da-9908-007ae96e1d8b" width="40px" />

Monthly gatherings connecting healthcare professionals, biotech entrepreneurs, AI researchers, and community builders exploring AI applications transforming drug discovery, patient care, and medical research.

</aside>

All levels welcome. Whether you're a pharmaceutical industry veteran, AI researcher, practicing physician, or simply curious about how AI is transforming healthcare—there's a place for you here.

Community Leads: Kris Krug & Simon Haworth Email: [email protected] LinkedIn: linkedin.com/in/simon-haworth-uk-us-prc

What Is Life Sciences AI Community?

A community-driven space bridging pharma, research institutions, BC's biotech ecosystem, and the broader AI community through knowledge sharing, partnership facilitation, and ethical deployment advocacy.

We're witnessing a 0% to 33% transformation in pharmaceutical drug development in just 12 months. One-third of new drugs now involve AI—in the most regulated, conservative industry on the planet. This is not theoretical. These are medications moving through FDA/Health Canada approval that will reach patients within years.

This community is where you learn what's actually happening from people working inside the transformation. Not hype. Not speculation. Real intelligence from pharmaceutical industry insiders, researchers making breakthroughs, and practitioners deploying AI in clinical settings.

The Pharmaceutical Transformation

0% to 33% in 12 Months

Last year (2024): Zero drugs in pharmaceutical development with AI assistance.

This year (2025): One-third of new drugs originated or substantially helped by AI.

What this means: The most regulated, conservative industry has integrated AI into drug development at unprecedented scale. These are actual medications that will save actual lives.

While tech media covers ChatGPT controversies, the pharmaceutical industry has already crossed the chasm. AI isn't coming to healthcare. It's here.

BC + AI × Life Sciences — Charter

Who Should Attend?

Healthcare Professionals

• Physicians and clinicians
• Nurses and clinical practitioners
• Hospital administrators
• Public health professionals
• Medical device specialists

Researchers & Academics

• University medical AI researchers
• Computational biologists
• Clinical trial specialists
• Health informatics experts
• Biomedical engineers

Biotech Entrepreneurs

• Drug discovery startup founders
• Medical technology innovators
• Life sciences investors
• Accelerator/incubator leaders

AI Technologists

• Machine learning researchers
• Healthcare AI developers
• Data scientists
• Technical architects
• Ethics researchers

Patients & Advocates

• Patient community representatives
• Healthcare advocates
• Policy stakeholders
• Anyone who cares about the future of medicine

What Happens at Our Gatherings?

Typical Session Format

Industry Intelligence Sharing

• Real-time updates from pharmaceutical transformation
• Research breakthroughs and clinical progress
• Regulatory landscape and approval pathways
• Investment and commercialization trends

Deep-Dive Discussions

• AI applications in drug discovery
• Clinical deployment challenges and solutions
• Ethical frameworks for healthcare AI